Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits

被引:56
作者
Bowes, MP
Zivin, JA
Thomas, GR
Thibodeaux, H
Fagan, SC
机构
[1] GENENTECH INC,DEPT CARDIOVASC RES,S SAN FRANCISCO,CA 94080
[2] WAYNE STATE UNIV,COLL PHARM,DETROIT,MI 48202
[3] HENRY FORD HOSP,DEPT PHARM,DETROIT,MI 48202
[4] HENRY FORD HOSP,DEPT NEUROL,DETROIT,MI 48202
关键词
D O I
10.1006/exnr.1996.0137
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Hemorrhagic transformation (HT) is a poorly understood yet frequent complication of stroke. A transient increase in blood pressure (BP) occurs immediately after experimental embolization in rabbits and we evaluated the relationship between this acute hypertensive response and subsequent hemorrhagic transformation, as well as the attenuation of this hypertensive response with an anesthetic dose of halothane, We also examined embolism-induced HT during infusion of the thrombolytic agents tissue plasminogen activator and streptokinase. A blood clot embolus was injected into the internal carotid artery and flushed into the middle cerebral artery. In the first experiment, BP was monitored in anesthetized or unanesthetized rabbits for 20 min prior to and up to 1 h after embolization. In the second experiment, animals were embolized half-way through an infusion of tPA (3.0 mg/kg; 20% administered as era iv bolus, with the remainder infused over 30 min) or streptokinase (30,000 U/kg iv infused over 30 min). In unanesthetized animals, the HT score (number of brain sections displaying visible HT) was significantly correlated with the peak mean arterial pressure recorded at embolization (r = 0.60, n = 24, P < 0.01). No relationship was observed between BP and HT score in animals anesthetized with halothane. Although HT incidence and extent were significantly related to elevated BP in the unanesthetized animals, halothane administration actually increased HT incidence. Embolization during thrombolytic infusion did mot increase the occurrence or severity of HT. These data suggest that acute hypertension, but not ongoing thrombolysis, is a significant risk factor for MT following cerebral embolization. (C) 1996 Academic Press, Inc.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 48 条
[1]  
AUSTIN SM, 1992, J GEN INTERN MED, V7, P197
[2]   GENETIC-HYPERTENSION AND INCREASED SUSCEPTIBILITY TO CEREBRAL-ISCHEMIA [J].
BARONE, FC ;
PRICE, WJ ;
WHITE, RF ;
WILLETTE, RN ;
FEUERSTEIN, GZ .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (02) :219-233
[3]   MONOCLONAL-ANTIBODY TO THE ICAM-1 ADHESION SITE REDUCES NEUROLOGICAL DAMAGE IN A RABBIT CEREBRAL EMBOLISM STROKE MODEL [J].
BOWES, MP ;
ZIVIN, JA ;
ROTHLEIN, R .
EXPERIMENTAL NEUROLOGY, 1993, 119 (02) :215-219
[4]   BLOOD-PRESSURE COURSE IN PATIENTS WITH ACUTE STROKE AND MATCHED CONTROLS [J].
BRITTON, M ;
CARLSSON, A ;
DEFAIRE, U .
STROKE, 1986, 17 (05) :861-864
[5]  
BROTT T, 1988, STROKE, V19, P8
[6]   URGENT THERAPY FOR STROKE .1. PILOT-STUDY OF TISSUE PLASMINOGEN-ACTIVATOR ADMINISTERED WITHIN 90 MINUTES [J].
BROTT, TG ;
HALEY, EC ;
LEVY, DE ;
BARSAN, W ;
BRODERICK, J ;
SHEPPARD, GL ;
SPILKER, J ;
KONGABLE, GL ;
MASSEY, S ;
REED, R ;
MARLER, JR .
STROKE, 1992, 23 (05) :632-640
[7]   CLINICAL RISKS OF THROMBOLYTIC THERAPY [J].
CALIFF, RM ;
FORTIN, DF ;
TENAGLIA, AN ;
SANE, DC .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (02) :A12-A20
[8]   INFLUENCE OF TISSUE PLASMINOGEN-ACTIVATOR AND HEPARIN ON CEREBRAL-ISCHEMIA IN A RABBIT MODEL [J].
CARTER, LP ;
GUTHKELCH, AN ;
OROZCO, J ;
TEMELTAS, O .
STROKE, 1992, 23 (06) :883-888
[9]   CEREBRAL HEMORRHAGIC RISK OF ASPIRIN OR HEPARIN-THERAPY WITH THROMBOLYTIC TREATMENT IN RABBITS [J].
CLARK, WM ;
MADDEN, KP ;
LYDEN, PD ;
ZIVIN, JA .
STROKE, 1991, 22 (07) :872-876
[10]   HEMODILUTION AND HYPERTENSION EFFECTS ON CEREBRAL-HEMORRHAGE IN CEREBRAL-ISCHEMIA IN RATS [J].
COLE, DJ ;
DRUMMOND, JC ;
RUTA, TS ;
PECKHAM, NH .
STROKE, 1990, 21 (09) :1333-1339